AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 7,000.00
+280.00 (4.17%)
Apr 10, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 188.79 billion as of April 10, 2026. Its market cap has decreased by -5.86% in one year.
Market Cap
188.79B
Enterprise Value
176.02B
Revenue
3.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,000.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 188.79B, a decrease of -55.40%. That is a compound annual growth rate of -11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 188.79B | -24.89% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 219.69B |
| Boditech Med | 214.03B |
| Samil Pharmaceutical Co.,Ltd | 203.80B |
| Suheung | 203.23B |
| Jeil Pharmaceutical Co.,Ltd | 195.11B |
| JW Lifescience | 192.47B |
| Whan In Pharm | 189.83B |
| REYON Pharmaceutical | 183.23B |